Variant report

Variant	esv1798003
Chromosome Location	chr4:110981611-110996948
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr4:110985490-110985821	HepG2	liver:	n/a	n/a
2	BHLHE40	chr4:110986172-110986215	K562	blood:	n/a	n/a
3	BHLHE40	chr4:110991725-110991942	K562	blood:	n/a	n/a
4	CEBPB	chr4:110985541-110985750	HepG2	liver:	n/a	chr4:110985675-110985686
5	CEBPB	chr4:110985499-110985850	K562	blood:	n/a	chr4:110985675-110985686
6	CEBPB	chr4:110996703-110996974	K562	blood:	n/a	chr4:110996834-110996845
7	CEBPB	chr4:110985478-110985826	K562	blood:	n/a	chr4:110985675-110985686
8	CEBPB	chr4:110985467-110985795	HepG2	liver:	n/a	chr4:110985675-110985686
9	CEBPB	chr4:110985453-110986046	HepG2	liver:	n/a	chr4:110985675-110985686
10	CEBPB	chr4:110985512-110985836	IMR90	lung:	n/a	chr4:110985675-110985686
11	CEBPB	chr4:110985507-110985778	K562	blood:	n/a	chr4:110985675-110985686
12	CEBPB	chr4:110996743-110996874	HepG2	liver:	n/a	chr4:110996834-110996845
13	CEBPB	chr4:110985508-110985857	MCF-7	breast:	n/a	chr4:110985675-110985686
14	CEBPB	chr4:110985511-110985799	Hela-S3	cervix:	n/a	chr4:110985675-110985686
15	CTCF	chr4:110995740-110995890	AoAF	blood vessel:	n/a	n/a
16	CTCF	chr4:110994300-110994450	K562	blood:	n/a	n/a
17	EP300	chr4:110983559-110983567	GM12878	blood:	n/a	n/a
18	EP300	chr4:110985438-110985825	HepG2	liver:	n/a	n/a
19	EP300	chr4:110985448-110985779	HepG2	liver:	n/a	n/a
20	EP300	chr4:110985594-110985771	HepG2	liver:	n/a	n/a
21	EP300	chr4:110985571-110985672	K562	blood:	n/a	n/a
22	ESR1	chr4:110992481-110992874	ECC-1	luminal epithelium:	n/a	n/a
23	FOS	chr4:110981851-110982013	MCF10A-Er-Src	breast:	n/a	n/a
24	FOXA1	chr4:110985413-110985781	HepG2	liver:	n/a	n/a
25	FOXA1	chr4:110985467-110985780	HepG2	liver:	n/a	n/a
26	FOXA1	chr4:110985396-110985801	HepG2	liver:	n/a	n/a
27	FOXA1	chr4:110985382-110985802	HepG2	liver:	n/a	n/a
28	FOXA2	chr4:110985468-110985751	HepG2	liver:	n/a	n/a
29	GATA1	chr4:110993933-110994857	PBDE	blood:	n/a	chr4:110994119-110994128 chr4:110994119-110994128
30	GATA2	chr4:110985522-110985820	SH-SY5Y	brain:	n/a	n/a
31	GATA2	chr4:110994260-110994528	SH-SY5Y	brain:	n/a	n/a
32	GATA2	chr4:110989466-110990019	SH-SY5Y	brain:	n/a	n/a
33	GATA2	chr4:110987174-110987609	SH-SY5Y	brain:	n/a	chr4:110987328-110987344 chr4:110987331-110987340
34	GATA3	chr4:110989280-110989980	SK-N-SH	brain:	n/a	chr4:110989326-110989336 chr4:110989328-110989338 chr4:110989326-110989335 chr4:110989328-110989335
35	GATA3	chr4:110987009-110987465	SH-SY5Y	brain:	n/a	chr4:110987328-110987344 chr4:110987331-110987340
36	GATA3	chr4:110985577-110985718	SH-SY5Y	brain:	n/a	n/a
37	GATA3	chr4:110985399-110985816	MCF-7	breast:	n/a	n/a
38	GATA3	chr4:110985550-110985773	MCF-7	breast:	n/a	n/a
39	GATA3	chr4:110989258-110989879	SH-SY5Y	brain:	n/a	chr4:110989326-110989336 chr4:110989328-110989338 chr4:110989326-110989335 chr4:110989328-110989335
40	GATA3	chr4:110989158-110990112	SK-N-SH	brain:	n/a	chr4:110989326-110989336 chr4:110989328-110989338 chr4:110989326-110989335 chr4:110989328-110989335
41	GATA3	chr4:110987087-110987541	MCF-7	breast:	n/a	chr4:110987328-110987344 chr4:110987331-110987340
42	HDAC2	chr4:110985516-110985818	HepG2	liver:	n/a	n/a
43	HNF4A	chr4:110985476-110985782	HepG2	liver:	n/a	n/a
44	HNF4A	chr4:110985403-110985891	HepG2	liver:	n/a	n/a
45	IRF1	chr4:110996378-110996440	K562	blood:	n/a	n/a
46	MAFF	chr4:110996284-110996432	K562	blood:	n/a	n/a
47	MAFK	chr4:110983267-110983429	HepG2	liver:	n/a	chr4:110983384-110983395 chr4:110983383-110983398 chr4:110983382-110983396 chr4:110983383-110983399 chr4:110983383-110983394 chr4:110983383-110983394
48	MAFK	chr4:110996276-110996536	K562	blood:	n/a	n/a
49	MXI1	chr4:110993987-110994712	SK-N-SH	brain:	n/a	n/a
50	MXI1	chr4:110985515-110985584	HepG2	liver:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:110992869-110992919	HCPEpiC	choroid plexus:	n/a
2	chr4:110992869-110992919	HPAEpiC	pulmonary alveolar:	n/a
3	chr4:110992869-110992919	Hepatocyte	liver:	n/a
4	chr4:110992869-110992919	AG09319	gingival:	n/a
5	chr4:110992869-110992919	AG10803	skin:	n/a
6	chr4:110992869-110992919	Caco-2	colon:	n/a
7	chr4:110992869-110992919	NH-A	brain:	n/a
8	chr4:110992869-110992919	HCT-116	colon:	n/a
9	chr4:110992869-110992919	SK-N-SH	brain:	n/a
10	chr4:110992869-110992919	H1-hESC	embryonic stem cell:	embryo
11	chr4:110992869-110992919	SK-N-SH_RA	brain:	n/a
12	chr4:110992869-110992919	LNCaP	prostate:	n/a
13	chr4:110992869-110992919	HEEpiC	esophagus:	n/a
14	chr4:110992869-110992919	GM12878	blood:	n/a
15	chr4:110992869-110992919	HCM	heart:	n/a
16	chr4:110992869-110992919	HL-60	blood:	n/a
17	chr4:110992869-110992919	HIPEpiC	eye:	n/a
18	chr4:110992869-110992919	BJ	skin:	n/a
19	chr4:110992869-110992919	ProgFib	skin:	n/a
20	chr4:110992869-110992919	GM19239	blood:	n/a
21	chr4:110992869-110992919	NHDF-neo	bronchial:	n/a
22	chr4:110992869-110992919	Jurkat	blood:	n/a
23	chr4:110992869-110992919	HAEpiC	amniotic membrane:	n/a
24	chr4:110992869-110992919	PANC-1	pancreas:	n/a
25	chr4:110992869-110992919	RPTEC	kidney:	n/a
26	chr4:110992869-110992919	GM06990	blood:	n/a
27	chr4:110992869-110992919	MCF10A-Er-Src	breast:	n/a
28	chr4:110992869-110992919	U87	brain:	n/a
29	chr4:110992869-110992919	SK-N-MC	brain:	n/a
30	chr4:110992869-110992919	HepG2	liver:	n/a
31	chr4:110992869-110992919	HRE	kidney:	n/a
32	chr4:110992869-110992919	AG04450	lung:	fetal
33	chr4:110992869-110992919	PFSK-1	brain:	n/a
34	chr4:110992869-110992919	T-47D	breast:	n/a
35	chr4:110992869-110992919	GM12891	blood:	n/a
36	chr4:110992869-110992919	AG04449	skin:	fetal
37	chr4:110992869-110992919	IMR90	lung:	fetal
38	chr4:110992869-110992919	HMEC	breast:	n/a
39	chr4:110992869-110992919	NHBE	bronchial:	n/a
40	chr4:110992869-110992919	HEK293	kidney:	embryo
41	chr4:110992869-110992919	NB4	blood:	n/a
42	chr4:110992869-110992919	A549	lung:	n/a
43	chr4:110992869-110992919	HCF	heart:	n/a
44	chr4:110992869-110992919	PrEC	prostate:	n/a
45	chr4:110992869-110992919	HNPCEpiC	eye:	n/a
46	chr4:110992869-110992919	CMK	blood:	n/a
47	chr4:110992869-110992919	AoSMC	blood vessel:	n/a
48	chr4:110992869-110992919	HRPEpiC	eye:	n/a
49	chr4:110992869-110992919	Hela-S3	cervix:	n/a
50	chr4:110992869-110992919	ECC-1	luminal epithelium:	n/a

No.	Distal block	Cell Line	Cell type
1	chr4:110982174..110983963-chr4:111117469..111119843,2	K562	blood:
2	chr4:110978929..110981764-chr4:111118255..111120738,2	K562	blood:
3	chr4:110977785..110984731-chr4:111116105..111121044,7	MCF-7	breast:
4	chr4:110989188..110991763-chr4:110992252..110995020,2	K562	blood:
5	chr4:110989188..110991763-chr4:110992252..110995020,2	K562	blood:
6	chr4:110979668..110982097-chr4:110982494..110984694,2	MCF-7	breast:

Variant related genes	Relation type
ELOVL6	TF binding region
ELOVL6	CpG island
ENSG00000170522	chromatin interactions

Extended variants
information (count: 578 )
Associated
traits (count: 76 )

Variant overlapped rSNPs/rCNVs (count:578 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs17041311	chr4:110981611-110981612	Weak transcription Strong transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs113503836	chr4:110981621-110981622	Weak transcription Strong transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs35966208	chr4:110981655-110981656	Weak transcription Strong transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs372840345	chr4:110981669-110981670	Weak transcription Strong transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs78161576	chr4:110981684-110981685	Weak transcription Strong transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs368584508	chr4:110981763-110981764	Weak transcription Strong transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs574466060	chr4:110981794-110981795	Weak transcription Strong transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs540139863	chr4:110981816-110981817	Weak transcription Strong transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs560354915	chr4:110981906-110981907	Weak transcription Strong transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs113448790	chr4:110981931-110981932	Weak transcription Strong transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs12505992	chr4:110981940-110981941	Weak transcription Strong transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs562524383	chr4:110981948-110981949	Weak transcription Strong transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs28564340	chr4:110981997-110981998	Weak transcription Strong transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs113622708	chr4:110981998-110981999	Weak transcription Strong transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs568064239	chr4:110982043-110982044	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs527241477	chr4:110982078-110982079	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs547065727	chr4:110982097-110982098	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs567200610	chr4:110982100-110982101	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs7683007	chr4:110982130-110982131	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs7682855	chr4:110982146-110982147	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs569316388	chr4:110982219-110982220	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs17041315	chr4:110982227-110982228	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs554598848	chr4:110982246-110982247	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs12498468	chr4:110982248-110982249	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs540272039	chr4:110982266-110982267	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs553879452	chr4:110982268-110982269	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs17041322	chr4:110982272-110982273	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs545765759	chr4:110982294-110982295	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs145147579	chr4:110982325-110982326	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs531484060	chr4:110982359-110982360	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs76296380	chr4:110982360-110982361	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs541954123	chr4:110982361-110982362	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs556070824	chr4:110982363-110982364	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs561803266	chr4:110982376-110982377	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs527375533	chr4:110982389-110982390	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs547396164	chr4:110982416-110982417	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs570336764	chr4:110982420-110982421	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs372967336	chr4:110982443-110982444	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs376402597	chr4:110982452-110982453	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs569112430	chr4:110982470-110982471	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs12645980	chr4:110982498-110982499	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs538010758	chr4:110982506-110982507	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs554733966	chr4:110982543-110982544	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs568264220	chr4:110982560-110982561	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs534010392	chr4:110982615-110982616	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs369743503	chr4:110982640-110982641	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs554174260	chr4:110982665-110982666	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs577132817	chr4:110982686-110982687	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs199676433	chr4:110982706-110982707	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs57846282	chr4:110982721-110982722	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:76)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	17603634	CNVD
Hepatocellular carcinoma	16750200	CNVD
Myxofibrosarcoma	16751306	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Breast cancer	16272173	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Lung cancer	19208797	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	21785460	CNVD
Myelodysplastic syndrome	21251322	CNVD
Lung cancer	18438408	CNVD
Cancer	22429812	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	21183584	CNVD
primary effusion lymphomas	17116491	CNVD
small cell lung cancer	20016488	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	17133270	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Colorectal cancer	20459617	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Congenital anomalies of the kidney and urinary tract	20505237	CNVD
Breast cancer	17393978	CNVD
Ovarian cancer	21720365	CNVD
Esophageal cancer	21851588	CNVD
Melanoma	20688739	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	16397240	CNVD
Schizophrenia	19546859	CNVD
Colorectal cancer	16272173	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Myelofibrosis	22110671	CNVD
Testicular germ cell tumor	18059402	CNVD
Ovarian cancer	22174824	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:279 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:110964600-110981800	Weak transcription	Brain Anterior Caudate	brain
2	chr4:110964600-111004000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
3	chr4:110964800-110982800	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
4	chr4:110965000-110982000	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
5	chr4:110965200-110986600	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
6	chr4:110965400-110994200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
7	chr4:110966800-110982000	Strong transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
8	chr4:110970800-110995800	Weak transcription	iPS-15b Cell Line	embryonic stem cell
9	chr4:110971800-110992800	Weak transcription	Fetal Stomach	stomach
10	chr4:110973000-110991000	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
11	chr4:110973000-111009200	Weak transcription	H1 Cell Line	embryonic stem cell
12	chr4:110973400-110982200	Weak transcription	K562	blood
13	chr4:110973400-110992400	Weak transcription	HUES64 Cell Line	embryonic stem cell
14	chr4:110974400-110990600	Weak transcription	H9 Cell Line	embryonic stem cell
15	chr4:110974600-110992600	Weak transcription	HUES6 Cell Line	embryonic stem cell
16	chr4:110977000-110982000	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
17	chr4:110977000-110983000	Weak transcription	Brain Angular Gyrus	brain
18	chr4:110977200-110985000	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
19	chr4:110977200-110992400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
20	chr4:110977200-110992600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
21	chr4:110979600-110982000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
22	chr4:110979600-110982000	Enhancers	Rectal Mucosa Donor 31	rectum
23	chr4:110979600-110982000	Enhancers	HMEC	breast
24	chr4:110979800-110982400	Enhancers	Primary T helper naive cells from peripheral blood	blood
25	chr4:110980200-110981800	Enhancers	Primary T killer memory cells from peripheral blood	blood
26	chr4:110980200-110982000	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
27	chr4:110980200-110982000	Enhancers	Muscle Satellite Cultured Cells	--
28	chr4:110980200-110982000	Enhancers	Small Intestine	intestine
29	chr4:110980200-110992600	Weak transcription	iPS-18 Cell Line	embryonic stem cell
30	chr4:110980200-111004000	Weak transcription	HUES48 Cell Line	embryonic stem cell
31	chr4:110980400-110982000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
32	chr4:110980600-110981800	Enhancers	A549	lung
33	chr4:110980600-110981800	Enhancers	NHDF-Ad	bronchial
34	chr4:110980600-110982000	Enhancers	Primary hematopoietic stem cells short term culture	blood
35	chr4:110980600-110982000	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
36	chr4:110980600-110982000	Enhancers	Fetal Intestine Small	intestine
37	chr4:110980600-110982000	Enhancers	HUVEC	blood vessel
38	chr4:110980600-110982200	Enhancers	Stomach Mucosa	stomach
39	chr4:110980600-110982600	Enhancers	Dnd41	blood
40	chr4:110980800-110982000	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
41	chr4:110980800-110982000	Enhancers	Osteobl	bone
42	chr4:110980800-110982200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
43	chr4:110980800-110985200	Weak transcription	HepG2	liver
44	chr4:110980800-110990800	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
45	chr4:110981000-110981800	Enhancers	Primary T helper cells PMA-I stimulated	--
46	chr4:110981000-110982000	Enhancers	Primary T helper cells fromperipheralblood	blood
47	chr4:110981000-110982000	Enhancers	Rectal Mucosa Donor 29	rectum
48	chr4:110981000-110982000	Enhancers	NHEK	skin
49	chr4:110981000-110982200	Enhancers	Brain Cingulate Gyrus	brain
50	chr4:110981000-110983200	Enhancers	Brain Hippocampus Middle	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links